BioNxt Solutions Inc.
BNXTF
$0.26
$0.015.90%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -345.45% | -34.40% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -345.45% | -34.40% | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -345.45% | -34.40% | -- |
| SG&A Expenses | -21.62% | 65.16% | 87.36% | 34.45% | 79.12% |
| Depreciation & Amortization | -89.80% | 119.51% | -80.37% | -76.33% | -70.66% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -19.18% | 56.65% | 61.62% | -5.32% | 49.05% |
| Operating Income | 19.18% | -56.65% | -63.37% | 4.93% | -49.28% |
| Income Before Tax | 14.21% | -121.91% | -69.69% | -8.34% | -31.98% |
| Income Tax Expenses | -- | -- | -120.90% | -- | -- |
| Earnings from Continuing Operations | 14.21% | -121.91% | -66.16% | -8.34% | -31.98% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 14.21% | -121.91% | -66.16% | -8.34% | -31.98% |
| EBIT | 19.18% | -56.65% | -63.37% | 4.93% | -49.28% |
| EBITDA | 18.74% | -58.58% | -66.50% | 3.67% | -53.22% |
| EPS Basic | 23.46% | -105.04% | -53.66% | -4.21% | -24.62% |
| Normalized Basic EPS | 14.00% | -65.22% | -51.79% | -1.69% | -21.95% |
| EPS Diluted | 23.46% | -105.04% | -53.66% | -4.21% | -24.62% |
| Normalized Diluted EPS | 14.00% | -65.22% | -51.79% | -1.69% | -21.95% |
| Average Basic Shares Outstanding | 11.96% | 8.56% | 7.48% | 4.09% | 5.77% |
| Average Diluted Shares Outstanding | 11.96% | 8.56% | 7.48% | 4.09% | 5.77% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |